Church & Dwight Co Inc (CHD)
Valor JustoFundamental
67
Precio
$94.22
Capitalización Bursátil
$22.68B
Parte 1 · Cuánto vale la empresa
Resumen
Church & Dwight Co., Inc. develops, manufactures, and markets household, personal care, and specialty products. It operates in three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers baking soda, cat litters, laundry detergents, carpet deodorizers, and other baking soda-based products under the ARM & HAMMER brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; dry shampoos under the BATISTE brand; water flossers under the WATERPIK brand; oral care products under the THERABREATH brand; acne treatment products under the HERO brand; hand sanitizers under the TOUCHLAND brand; and condoms, lubricants, and vibrators under the TROJAN brand. It also provides home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; and cold shortening and relief products under the ZICAM brand. In addition, the company's specialty products include animal and food productivity products, such as ARM & HAMMER baking soda as a feed additive to help dairy cow; BIO-CHLOR and FERMENTEN used to reduce health issues associated with calving, as well as needed protein; CELMANAX refined functional carbohydrate, a yeast-based prebiotic; and CERTILLUS a probiotics products used in the poultry, dairy, beef, and swine industries. Additionally, it offers sodium bicarbonate; and cleaning and deodorizing products. The company sells its consumer products through supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar and other discount stores, pet and other specialty stores, websites and other e-commerce channels; and specialty products to industrial customers and livestock producers through distributors. Church & Dwight Co., Inc. was founded in 1846 and is headquartered in Ewing, New Jersey.
No editorial profile for this company yet
Direct competitors
Who this company fights with for the same customers
Generated on 18 de septiembre de 2026 with claude-haiku-4-5 — shared with all users
P&G is the first competitor named in Church & Dwight's own 10-K and fights for the same US shelf space in laundry detergent (Tide versus Arm & Hammer and Xtra), oral care and personal care.
Clorox is the closest rival by size and profile, competing on the same US household aisle in laundry additives, cleaners and cat litter (Fresh Step versus Arm & Hammer).
Colgate-Palmolive competes head-on in oral care against Arm & Hammer toothpaste, Spinbrush and TheraBreath, and in home care and pet products sold through the same retailers.
Kenvue competes in consumer self-care, where its Listerine, Neutrogena and cold-and-allergy brands sit against TheraBreath, Hero acne treatment and Zicam.
Reckitt competes across cleaning and health-and-hygiene categories where Church & Dwight also sells, from surface cleaners to sexual wellness products rivaling Trojan.
Unilever competes in personal care and home care worldwide, with dry shampoo, deodorant and laundry brands aimed at the same shoppers as Batiste and Arm & Hammer.
Balance y Liquidez
Ingresos
$6.23B
Últimos 12 meses (hasta 30/6/2026)
Beneficio Neto
$745M
Últimos 12 meses (hasta 30/6/2026)
Flujo de Caja Libre
$1.09B
Patrimonio Neto Total
$4.00B
Pasivo Total
$4.91B
Ratio de Liquidez
1.15
Cobertura de Intereses
11.26
Deuda/EBITDA
1.87
Beneficio Por Acción
Ingresos y Beneficio Neto
Flujo de Caja Libre
Desglose de Ingresos
Estado histórico
Márgenes en el tiempo
La deuda en el tiempo
Cuánto pesa la deuda
Cuadro de crecimiento
Crecimiento — Ingresos
Estimación de Valor Justo
Valor Justo
$80.51
Precio Actual
$94.22
Margen de Seguridad
-17.0%
Rango de Valor Justo
$56.29 - $104.72
Dispersión entre los métodos de valoración utilizados, no un intervalo de confianza calibrado estadísticamente.
Métodos de Estimación
Métricas de Valoración
Ratio P/E
30.30
ROE
18.4%
Ratio P/B
5.14
P/FCF
20.75
Margen Bruto
45.6%
ROIC
11.1%
Radar de Rentabilidad
Creación de Valor (Ventaja Competitiva)
ROIC
11.1%
WACC
7.5%
ROIC − WACC
+3.5 pp
El ROIC supera el coste del capital: la empresa está creando valor para los accionistas.
Criterios de Análisis Fundamental
Superado (19)
- EPS shows upward trend
- Price CAGR 7.86%
- ROIC 11.0%
- Gross Margin 45.6%
- P/FCF 20.75
- Debt/Equity ratio
- Operating Margin 17.5%
- Positive Free Cash Flow
- CapEx intensity
- Current Ratio
- Interest Coverage
- Debt/EBITDA
- Return on Tangible Assets
- ROE 17.8%
- Analyst Consensus 50% Buy
- Earnings Quality (OCF/NI) 1.65
- Share Dilution -1.2%
- Net Margin Trend 12.0% vs 8.7%
- Piotroski F-Score 6/9
Fallido (7)
- EPS CAGR 0.49%
- P/B Ratio 5.14
- Low reliance on intangibles
- Price below Graham Number
- DCF valuation (Overvalued)
- Revenue Growth 5Y 4.8%
- Earnings Surprise avg 2.5%
No disponible (2)
- Dividend Payout NaN%
- PEG Ratio (need PE > 0 and growth > 0)
Piotroski F-Score
Señales mixtas: algunas áreas requieren atención
Calidad de los Beneficios
Alta calidad: beneficios respaldados por efectivo
Dilución de Acciones
Recomprando acciones. Favorable para el accionista
Participaciones institucionales
Gobernanza
Equipo Directivo
| Nombre | Cargo | Edad |
|---|---|---|
| Mr. Richard A. Dierker | President, CEO & Director | 45 |
| Mr. Lee B. McChesney | CFO & Executive VP | 53 |
| Mr. Patrick D. de Maynadier Esq., J.D. | Executive VP, General Counsel & Secretary | 65 |
| Mr. Michael G. Read | Executive Vice President of International | 50 |
| Mr. Charles R. Raup | Executive VP & President of US Domestic | 57 |
| Mr. Joseph James Longo | VP, Chief Accounting Officer & Corporate Controller | 54 |
| Mr. Carlos G. Linares | Executive VP, CTO & Global New Product Innovation | 61 |
| Ms. Stacey Ramstedt | Senior VP & Chief Marketing Officer | - |
| Ms. Rene M. Hemsey | Executive VP & Chief Human Resources Officer | 57 |
| Mr. Brian Buchert | Executive VP of Strategy, M&A and Business Partnerships | - |
Riesgo de Auditoría
4
Riesgo del Consejo
4
Riesgo de Compensación
2
Riesgo de Derechos del Accionista
5
Parte 2 · El precio y el momento de entrar
Esta parte no sirve para saber si la empresa vale: sirve para elegir cuándo comprarla, una vez que los fundamentales te han convencido. Dentro: análisis técnico, potencial, caídas históricas, exposición gamma.
Documentos
- Ver documento
Informe anual (10-K)
Un resumen anual del negocio, los resultados financieros y los riesgos de la empresa.
Presentado el 2026-02-12
- Ver documento
Informe trimestral (10-Q)
Una actualización del desempeño financiero de los últimos tres meses.
Presentado el 2026-07-31
- Ver documento
Informe de hecho relevante (8-K)
Un aviso sobre un hecho relevante, como un cambio de dirección o un anuncio importante.
Presentado el 2026-07-31
via SEC EDGAR
Historial de Resultados
via SEC EDGAR
Latest News
Recent headlines for CHD, sourced from Markets Gazette.